Focus: Heidelberg Pharma is a German-based public company focused on diagnostic and therapeutic products for oncology. The company operates in a specialized niche within the broader oncology market.
Profile data last refreshed 7h ago · AI intelligence enriched 2mo ago
No open roles listed right now. Follow Heidelberg Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Heidelberg Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Heidelberg Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Simris steps on Heidelberg Pharma’s toes with amanitin pivot - European Biotechnology Magazine
Simris steps on Heidelberg Pharma’s toes with amanitin pivot European Biotechnology Magazine
Huadong Med stock steadies as investors watch China pharma policy and recent partnerships - ad-hoc-news.de
Huadong Med stock steadies as investors watch China pharma policy and recent partnerships ad-hoc-news.de
SZD Stock Price and Chart — HAM:SZD - TradingView
SZD Stock Price and Chart — HAM:SZD TradingView
Heidelberg Pharma deepens ADC alliance with Huadong - European Biotechnology Magazine
Heidelberg Pharma deepens ADC alliance with Huadong European Biotechnology Magazine
Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China - Yahoo Finance
Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China Yahoo Finance
Heidelberg Pharma Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Heidelberg Pharma Number of Employees 2026 | Employee Count & Headcount Data Revelio Labs
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Major organizational upheaval and talent exodus indicate severe business or strategic challenges; high execution and job-security risk for new hires.